Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

OPRX
OptimizeRx Corporation Common Stock
stock NASDAQ

At Close
May 8, 2025 3:59:57 PM EDT
9.89USD+4.325%(+0.41)237,436
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 8, 2025 8:39:36 AM EDT
10.29USD+8.544%(+0.81)1,250
After-hours
May 8, 2025 4:00:30 PM EDT
9.91USD-0.101%(-0.01)375
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
08:00AM EST  OptimizeRx Corp. (the Company)(Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced today that members of its leadership team will attend and present at the upcoming 11th Annual SVB Leerink Global Healthcare Conference and BTIGs MedTech, Digital Health, Life Science & Diagnostic Tools Conference.   GlobeNewswire Inc
Jan 18, 2022
08:00AM EST  OptimizeRx Corp. (the Company)(Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced it has been named a winner in the 2022 BIG Innovation Awards presented by the Business Intelligence Group.   GlobeNewswire Inc
Jan 3, 2022
08:00AM EST  OptimizeRx to Participate in Panel Presentation at LifeSci   GlobeNewswire Inc
Dec 29, 2021
08:00AM EST  OptimizeRx Corp. (the Company)(Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced its Evidence-based Physician Engagement solution has been recognized as one of the most innovative products of the year for life sciences by PM360.   GlobeNewswire Inc
Dec 22, 2021
08:00AM EST  OptimizeRx Corp.(the Company) (Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today issued an open letter from the CEO to shareholders detailing the completion of internal management changes. The full letter is published below:   GlobeNewswire Inc
Dec 15, 2021
02:38PM EST  OptimizeRx Survey Addresses Treatment Selection, Discontinuation   GlobeNewswire Inc
Dec 8, 2021
08:00AM EST  - COVID-19 Consumer Health Communications Campaign won silver in the Mobile Digital Health Resources: Text Messaging category- TelaRep Interactive EHR Communication received a merit award in the Connected Digital Health: Clinical Decision Support Tools category   GlobeNewswire Inc
Nov 23, 2021
08:00AM EST  OptimizeRx Ranked Among Fastest-Growing Companies in North America   GlobeNewswire Inc
Nov 22, 2021
08:00AM EST  OptimizeRx Corp. (the Company)(Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that the management team will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference.   GlobeNewswire Inc
Nov 16, 2021
08:00AM EST  OptimizeRx and Reuters Events Team Up with I AM   GlobeNewswire Inc
Nov 10, 2021
08:57AM EST  RBC Capital Maintains Outperform on OptimizeRx, Raises Price Target to $100   Benzinga
Nov 9, 2021
05:50PM EST  OptimizeRx Q3 EPS $0.09 Misses $0.13 Estimate, Sales $16.13M Beat $15.06M Estimate   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Nov 5, 2021
08:00AM EDT  Predictive Analytics Solutions Create New Opportunities for Life   GlobeNewswire Inc
Oct 27, 2021
08:00AM EDT  OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call onTuesday, November 9, 2021, at 4:30 p.m. Eastern Timeto discuss its results for the third quarter, endedSeptember 30, 2021. The financial results will be issued in a press release prior to the call.   GlobeNewswire Inc
Oct 25, 2021
07:39AM EDT  OptimizeRx To Participate In Fireside Chat At Credit Suisse 30th Annual Healthcare Conference   Benzinga
07:30AM EDT  OptimizeRx to Participate in Fireside Chat at the Credit Suisse   GlobeNewswire Inc
Sep 30, 2021
10:50AM EDT  OptimizeRx Gains 14% After Appointment Of New CFO Cum COO   RTTNews
07:36AM EDT  OptimizeRx Appoints Edward Stelmakh As CFO And COO   Benzinga
07:30AM EDT  OptimizeRx Appoints Seasoned Financial and Operational Executive,   GlobeNewswire Inc
06:30AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.15 A.M. EDT).   RTTNews
Sep 29, 2021
06:40PM EDT  OptimizeRx Set to Join S&P SmallCap 600   PR Newswire
05:25PM EDT  OptimizeRx Set to Join S&P SmallCap 600, To Replace Lydall, Effective Monday, October 4th   Benzinga
08:00AM EDT  OptimizeRx Survey Demonstrates Value of Digital Solutions in   GlobeNewswire Inc
Sep 14, 2021
08:12AM EDT  OptimizeRx Announces Significant Platform Enhancement To Digitize Pharmaceutical Access Solutions   Benzinga
08:00AM EDT  OptimizeRx Announces Significant Platform Enhancement to Digitize   GlobeNewswire Inc
Sep 8, 2021
08:00AM EDT  OptimizeRx Corp.(the Company) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has appointed Andrew DSilva to the new position of senior vice president of corporate finance.   GlobeNewswire Inc
Sep 7, 2021
08:00AM EDT  OptimizeRx Recognized as a Finalist in Questexs   GlobeNewswire Inc
Sep 1, 2021
08:00AM EDT  OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo, OptimizeRxs CEO, will present at the upcoming Lake Street Capital Markets, The Best Ideas Growth (BIG5) Conference and the Piper Sandler, Heartland Summit conferences.   GlobeNewswire Inc
Aug 17, 2021
08:06AM EDT  OptimizeRx Reports Partnership With Demandbase For Exclusive Account-Based Experience, No Terms Disclosed   Benzinga
08:00AM EDT  OptimizeRx and Demandbase Form Exclusive Account-Based-Experience   GlobeNewswire Inc
Aug 4, 2021
05:04PM EDT  OptimizeRx: Q2 Earnings Insights   Benzinga
04:42PM EDT  OptimizeRx Q2 EPS $0.10 Beats $0.07 Estimate, Sales $13.60M Beat $12.45M Estimate   Benzinga
04:01PM EDT  OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Jul 14, 2021
08:09AM EDT  OptimizeRx Announces Agreement With A Top Pharmaceutical Manufacturer To Use Its Physician Engagement   Benzinga
Jun 15, 2021
08:00AM EDT  OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, discusses aspects of the Companys 2021 strategic operating plan which has been aligned with the pharma industrys market sizing opportunity across fast growing specialty therapeutic areas.   GlobeNewswire Inc
Jun 1, 2021
08:00AM EDT  OptimizeRx Named to LD Micros   GlobeNewswire Inc
May 25, 2021
08:00AM EDT  OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that Will Febbo, OptimizeRxs, CEO will participate in a fireside chat at the William Blair 41st Annual Growth Stock Conference.   GlobeNewswire Inc
May 11, 2021
08:00AM EDT  OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will participate in RBC Capital Markets Global Healthcare Virtual Conference.   GlobeNewswire Inc
May 6, 2021
04:45PM EDT  OptimizeRx Q1 EPS $0.03 Beats $0.01 Estimate, Sales $11.20M Beat $10.47M Estimate   Benzinga
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
Apr 28, 2021
08:00AM EDT  OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Thursday, May 6, 2021, at 4:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2021. The financial results will be issued in a press release prior to the call.   GlobeNewswire Inc
Apr 27, 2021
07:52AM EDT  OptimizeRx Says Expands Omni-Channel Platform Reach At Point-Of-Care   Benzinga
07:51AM EDT  OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care   GlobeNewswire Inc
Apr 13, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021   Benzinga
07:51AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians, and patients, has received the ranking of #277 by the Financial Times (FT) list of The Americas Fastest Growing Companies 2021. This recognition is presented by the FT and Statista Inc., the world-leading statistics portal and industry ranking provider.   GlobeNewswire Inc
07:33AM EDT  RBC Capital Initiates Coverage On OptimizeRx with Outperform Rating, Announces Price Target of $65   Benzinga
Mar 16, 2021
12:25PM EDT  Return On Capital Employed Overview: OptimizeRx   Benzinga
07:36AM EDT  OptimizeRx Announces 19 New Enterprise-Level Deals For 2021; Financial Details Not Disclosed   Benzinga
07:30AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has secured 19 new enterprise-level deals for 2021 that provide access to the companys full suite of solutions and nationwide digital healthcare platform.   GlobeNewswire Inc
Mar 3, 2021
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the 33rd Annual ROTH Growth Conference being held virtually on March 15-17, 2021.   GlobeNewswire Inc
Feb 25, 2021
10:22AM EST  Roth Capital Maintains Buy on OptimizeRx, Raises Price Target to $85   Benzinga
Feb 24, 2021
04:09PM EST  OptimizeRx Q4 EPS $0.16 Beats $0.15 Estimate, Sales $16.40M Beat $16.02M Estimate   Benzinga
04:01PM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the fourth quarter and full year ended December 31, 2020. Quarterly and full year comparisons are to the same year-ago period.   GlobeNewswire Inc
03:35AM EST  Earnings Scheduled For February 24, 2021   Benzinga
Feb 23, 2021
07:31AM EST  OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its senior vice president and principal of agency channels, Angelo Campano, has been named to MM+Ms 2021 40 Under 40 list for his accomplishments and contributions to the healthcare marketing industry.   GlobeNewswire Inc
Feb 18, 2021
07:31AM EST  OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call   GlobeNewswire Inc
Feb 16, 2021
07:31AM EST  OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the SVB Leerink 10th Annual Global Healthcare Conference being held virtually on February 22-26, 2021.   GlobeNewswire Inc
Feb 9, 2021
12:31PM EST  OptimizeRx Snags Equity Capital Raise of $65.6M   Benzinga
09:10AM EST  OptimizeRx Announces Pricing of Public Offering of Common Stock   GlobeNewswire Inc
Feb 8, 2021
04:18PM EST  OptimizeRx Announces Proposed Public Offering Of Common Stock; Size Not Disclosed   Benzinga
04:18PM EST  OptimizeRx Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Jan 25, 2021
07:49AM EST  OptimizeRx Expects Q4 Revenue Of $16 Mln, Up 117% From Prior Year   RTTNews
07:35AM EST  Optimize RX Sees Q4 2020 Revs. $16M, Sees FY 2020 $43M   Benzinga
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020.   GlobeNewswire Inc
Jan 21, 2021
07:31AM EST  OptimizeRxCorp.(Nasdaq: OPRX), a leadingprovider of digital health solutions for life science companies, physicians and patients, has been invited to present at the B. Riley Securities 2021 Vision Day Conference being held virtually on January 28, 2021.   GlobeNewswire Inc
Jan 8, 2021
09:41AM EST  Roth Capital Maintains Buy on OptimizeRx, Raises Price Target to $70   Benzinga
Jan 6, 2021
07:31AM EST  OptimizeRxCorp.(Nasdaq: OPRX), a leadingprovider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwrights BioConnect Conference being held virtually on January 11-14, 2021.   GlobeNewswire Inc
Dec 11, 2020
07:31AM EST  OptimizeRxCorp.(Nasdaq: OPRX), a leadingprovider of digital health solutions for life science companies, physicians and patients, announced its virtual communication solution, TelaRepTM , has been recognized as one of the most innovative products for life sciences by PM360 Magazine.   GlobeNewswire Inc
Dec 9, 2020
07:32AM EST  OptimizeRx CEO, William Febbo, To Speak At Bank Of America 4th Annual HCIT And Digital Health Symposium Today, December 9, 2020   Benzinga
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to participate at the Bank of America 4th Annual HCIT and Digital Health Symposium on December 9-10.   GlobeNewswire Inc
Dec 7, 2020
07:32AM EST  OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care   Benzinga
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with Komodo Health, a data-driven healthcare software company with access to the broadest array of real-world data across patients, practitioners, and health systems.   GlobeNewswire Inc
Dec 1, 2020
07:35AM EST  OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform   Benzinga
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has introduced a transformative enhancement to its digital health and communications platform.   GlobeNewswire Inc
Nov 18, 2020
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, has ranked 432 on Deloittes Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. OptimizeRx grew revenue 217% from 2016 to 2019.   GlobeNewswire Inc
Nov 17, 2020
10:30AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with information services provider, Fierce Life Sciences, to develop a collaborative, design thinking event to tackle some of the biggest challenges facing healthcare.   GlobeNewswire Inc
Nov 16, 2020
10:02AM EST  68 Stocks Trading Near 52-Week Highs Just After Open On Monday, Nov. 16, 2020:   Benzinga
Nov 11, 2020
07:31AM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has appointed Angelo Campano to the new position of senior vice president and principal of agency channels.   GlobeNewswire Inc
Nov 9, 2020
04:45PM EST  OptimizeRx: Q3 Earnings Insights   Benzinga
04:04PM EST  OptimizeRx Q3 Adj. EPS $0.07 Beats $0.04 Estimate, Sales $10.50M Beat $9.77M Estimate   Benzinga
04:01PM EST  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, reported results for the three and nine months ended September 30, 2020. Quarterly and nine months comparisons are to the same year-ago period.   GlobeNewswire Inc
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Oct 26, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Monday, November 9, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. OptimizeRx management will host the call, followed by a question and answer period.   GlobeNewswire Inc
Oct 20, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to participate in two investor conferences being held in November.   GlobeNewswire Inc
Oct 13, 2020
07:48AM EDT  OptimizeRx Expects Q3 Revenue To Total More Than $10.0 Mln   RTTNews
07:35AM EDT  OptimizeRx Sees Prelim. Q3 Sales Over $10M vs $9.1M Est.   Benzinga
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited revenue for its third quarter ended September 30, 2020.   GlobeNewswire Inc
Oct 5, 2020
09:46AM EDT  Corporation for Potential Breaches of Fiduciary Duty By Its Board of Directors   PR Newswire
Sep 21, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will resume its webinar series this week with a panel of industry experts and thought leaders presenting innovative ideas for improving medication launches.   GlobeNewswire Inc
Sep 15, 2020
07:48AM EDT  OptimizeRx Reports Partnership With Epion Health To Provide Adherence, Affordability Support At Point Of Care   Benzinga
07:31AM EDT  Patients Gain Direct Access to Financial Assistance Relevant to Their Health Journey Prior to Their Medical Appointment   GlobeNewswire Inc
Sep 13, 2020
02:25PM EDT  Cramer Advises Viewers On Applied Materials, Blackstone And More   Benzinga
Sep 9, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, providers and patients, has been invited to participate in two investor conferences being held in September.   GlobeNewswire Inc
Aug 20, 2020
08:00AM EDT  OptimizeRx Enters Retail Pharmacies, Supporting Adherence by   GlobeNewswire Inc
Aug 5, 2020
04:05PM EDT  OptimizeRx Q2 EPS $0.02 Beats $(0.03) Estimate, Sales $8.78M Beat $7.97M Estimate   Benzinga
04:01PM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the second quarter and six months ended June 30, 2020. Quarterly and first half comparisons are to the same year-ago period.   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 27, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers, providers and patients, has completed the latest expansion of its digital health communication network in collaboration with Change Healthcare (Nasdaq: CHNG).   GlobeNewswire Inc
Jul 23, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Wednesday, August 5, 2020 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. The financial results will be issued in a press release prior to the call.   GlobeNewswire Inc
Jul 21, 2020
07:31AM EDT  OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has appointed Greg Wasson, former president and CEO of Walgreen Boots Alliance, to its board of directors.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC